Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 64,800
+2,400 (3.85%)
At close: Feb 25, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 946.08 billion as of February 25, 2026.
Market Cap
946.08B
Enterprise Value
472.43B
Revenue
283.31B
Ranking
n/a
PE Ratio
10.11
Stock Price
64,800.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 946.08B, a decrease of -46.84%. That is a compound annual growth rate of -79.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 911.04B | -9.43% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mezzion Pharma | 4.03T |
| G2GBIO | 1.66T |
| HK inno.N | 1.61T |
| Samyang Biopharm | 765.15B |
| ImmuneOncia Therapeutics | 631.89B |
| HEM Pharma | 585.93B |
| CellBion | 396.49B |
| DAE HWA Pharmaceutical | 267.65B |